#Healthcare Economy
Total 2 articles
EconomyEN
Novartis SciNeuro Alzheimer Deal 2026: A $1.7 Billion Bet on Brain Health
Novartis enters a $1.7 billion Novartis SciNeuro Alzheimer deal 2026 to develop next-gen anti-amyloid treatments using blood-brain barrier shuttle technology.
EconomyEN
Canadian Pharmacy Platform to Facilitate India-Sourced Ozempic Sales for US Patients
A Canadian pharmacy platform is now offering India-sourced Ozempic to US patients, aiming to bypass high domestic costs and supply shortages. Explore the impact on the pharma market.
